{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:51:42Z","timestamp":1777953102379,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.7759\/cureus.108234","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:04:11Z","timestamp":1777903451000},"source":"Crossref","is-referenced-by-count":0,"title":["Extensive Cutaneous and Scalp Metastases From Hormone Receptor-Positive Breast Cancer Successfully Treated With CDK4\/6 Inhibitor Therapy: A Case Report"],"prefix":"10.7759","author":[{"given":"Ricardo","family":"Fern\u00e1ndez-Ferreira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"Bautista-Pi\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireya","family":"Barrag\u00e1n-Dessavre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgina","family":"Cruz-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Monta\u00f1o-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Salas-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa Mar\u00eda","family":"Vicu\u00f1a-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Anaya-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Moreno-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra-Mar\u00eda","family":"Garc\u00eda-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel-Alicia","family":"Loya-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-63. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref2","article-title":"Cancer Statistics for the Year 2020: An Overview","author":"Ferlay J","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al.. Cancer Statistics for the Year 2020: An Overview. International Agency for Research on Cancer, Lyon, France; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1987.13","article-title":"The clinical course of bone metastases from breast cancer","volume":"55","author":"Coleman RE","year":"1987","unstructured":"Coleman RE, Rubens RD. The clinical course of bone metastases from breast cancer. Br J Cancer. 1987, 55:61-6. 10.1038\/bjc.1987.13","journal-title":"Br J Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/srep45411","article-title":"Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study","volume":"7","author":"Gong Y","year":"2017","unstructured":"Gong Y, Liu YR, Ji P, Hu X, Shao ZM. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Sci Rep. 2017, 7:45411. 10.1038\/srep45411","journal-title":"Sci Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15856","article-title":"Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study","volume":"8","author":"Wu Q","year":"2017","unstructured":"Wu Q, Li J, Zhu S, et al.. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. 2017, 8:27990-6. 10.18632\/oncotarget.15856","journal-title":"Oncotarget"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12788\/cutis.0223","article-title":"Cutaneous manifestation as initial presentation of metastatic breast cancer: a systematic review","volume":"107","author":"Johnson C","year":"2021","unstructured":"Johnson C, Friedmann DP, Gade A, et al.. Cutaneous manifestation as initial presentation of metastatic breast cancer: a systematic review. Cutis. 2021, 107:E29-36. 10.12788\/cutis.0223","journal-title":"Cutis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino G","year":"2004","unstructured":"Arpino G, Bardou VJ, Clark GM, Elledge RM. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res. 2004, 6:R149-56. 10.1186\/bcr767","journal-title":"Breast Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14151638","article-title":"Diagnosis and management of scalp metastases: a review","volume":"14","author":"Cedirian S","year":"2024","unstructured":"Cedirian S, Rapparini L, Sechi A, Piraccini BM, Starace M. Diagnosis and management of scalp metastases: a review. Diagnostics (Basel). 2024, 14:1638. 10.3390\/diagnostics14151638","journal-title":"Diagnostics (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/229255030901700105","article-title":"Metastatic cutaneous breast carcinoma: a case report and review of the literature","volume":"17","author":"Nava G","year":"2009","unstructured":"Nava G, Greer K, Patterson J, Lin KY. Metastatic cutaneous breast carcinoma: a case report and review of the literature. Can J Plast Surg. 2009, 17:25-7. 10.1177\/229255030901700105","journal-title":"Can J Plast Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2012.05635.x","article-title":"Patterns of skin metastases: a review of 25 years' experience at a single cancer center","volume":"53","author":"Wong CY","year":"2014","unstructured":"Wong CY, Helm MA, Helm TN, Zeitouni N. Patterns of skin metastases: a review of 25 years' experience at a single cancer center. Int J Dermatol. 2014, 53:56-60. 10.1111\/j.1365-4632.2012.05635.x","journal-title":"Int J Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson NK","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, et al.. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85:365-76. 10.1093\/jnci\/85.5.365","journal-title":"J Natl Cancer Inst"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008918310251","article-title":"The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version","volume":"9","author":"Montazeri A","year":"2000","unstructured":"Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, Haji-Mahmoodi M. The EORTC breast cancer-specific quality of life questionnaire (EORTC QLQ-BR23): translation and validation study of the Iranian version. Qual Life Res. 2000, 9:177-84. 10.1023\/a:1008918310251","journal-title":"Qual Life Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02590.x","article-title":"Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal","volume":"22","author":"Hu SC","year":"2008","unstructured":"Hu SC, Chen GS, Lu YW, Wu CS, Lan CC. Cutaneous metastases from different internal malignancies: a clinical and prognostic appraisal. J Eur Acad Dermatol Venereol. 2008, 22:735-40. 10.1111\/j.1468-3083.2008.02590.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2014.46.2.194","article-title":"Case series of different onset of skin metastasis according to the breast cancer subtypes","volume":"46","author":"Cho J","year":"2014","unstructured":"Cho J, Park Y, Lee JC, Jung WJ, Lee S. Case series of different onset of skin metastasis according to the breast cancer subtypes. Cancer Res Treat. 2014, 46:194-9. 10.4143\/crt.2014.46.2.194","journal-title":"Cancer Res Treat"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20153842","article-title":"Cutaneous metastasis of a breast cancer diagnosed 13 years before","volume":"90","author":"Bittencourt Mde J","year":"2015","unstructured":"Bittencourt Mde J, Carvalho AH, Nascimento BA, Freitas LK, Parij\u00f3s AM. Cutaneous metastasis of a breast cancer diagnosed 13 years before. An Bras Dermatol. 2015, 90:134-7. 10.1590\/abd1806-4841.20153842","journal-title":"An Bras Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.55395","article-title":"Cutaneous metastases from carcinoma breast: the common and the rare","volume":"75","author":"Prabhu S","year":"2009","unstructured":"Prabhu S, Pai SB, Handattu S, Kudur MH, Vasanth V. Cutaneous metastases from carcinoma breast: the common and the rare. Indian J Dermatol Venereol Leprol. 2009, 75:499-502. 10.4103\/0378-6323.55395","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2018.08.002","article-title":"Scalp metastasis from occult primary breast carcinoma: a case report and review of the literature","volume":"4","author":"Alizadeh N","year":"2018","unstructured":"Alizadeh N, Mirpour H, Azimi SZ. Scalp metastasis from occult primary breast carcinoma: a case report and review of the literature. Int J Womens Dermatol. 2018, 4:230-5. 10.1016\/j.ijwd.2018.08.002","journal-title":"Int J Womens Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0342-0","article-title":"Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling","volume":"118","author":"Lemieux J","year":"2009","unstructured":"Lemieux J, Amireault C, Provencher L, Maunsell E. Incidence of scalp metastases in breast cancer: a retrospective cohort study in women who were offered scalp cooling. Breast Cancer Res Treat. 2009, 118:547-52. 10.1007\/s10549-009-0342-0","journal-title":"Breast Cancer Res Treat"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.06.2011.4398","article-title":"Cutaneous metastases from breast carcinoma","volume":"2011","author":"Ahmed M","year":"2011","unstructured":"Ahmed M. Cutaneous metastases from breast carcinoma. BMJ Case Rep. 2011, 2011:4398. 10.1136\/bcr.06.2011.4398","journal-title":"BMJ Case Rep"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1188\/02.CJON.255-260","article-title":"Cutaneous metastatic breast cancer","volume":"6","author":"Moore S","year":"2002","unstructured":"Moore S. Cutaneous metastatic breast cancer. Clin J Oncol Nurs. 2002, 6:255-60. 10.1188\/02.CJON.255-260","journal-title":"Clin J Oncol Nurs"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20164572","article-title":"Cutaneous metastasis as the first manifestation of occult malignant breast neoplasia","volume":"91","author":"Weimann ET","year":"2016","unstructured":"Weimann ET, Botero EB, Mendes C, Santos MA, Stelini RF, Zelenika CR. Cutaneous metastasis as the first manifestation of occult malignant breast neoplasia. An Bras Dermatol. 2016, 91:105-7. 10.1590\/abd1806-4841.20164572","journal-title":"An Bras Dermatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20175870","article-title":"Cutaneous metastases in a patient with no previous diagnosis of cancer: diagnostic challenge","volume":"92","author":"Torraca PF","year":"2017","unstructured":"Torraca PF, Castro BC, Hans G Filho, Lima AM. Cutaneous metastases in a patient with no previous diagnosis of cancer: diagnostic challenge. An Bras Dermatol. 2017, 92:47-9. 10.1590\/abd1806-4841.20175870","journal-title":"An Bras Dermatol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.11138\/gchir\/2016.37.3.136","article-title":"An unexpected metastasis of breast cancer mimicking wheal rush","volume":"37","author":"Damaskos C","year":"2016","unstructured":"Damaskos C, Dimitroulis D, Pergialiotis V, et al.. An unexpected metastasis of breast cancer mimicking wheal rush. G Chir. 2016, 37:136-8. 10.11138\/gchir\/2016.37.3.136","journal-title":"G Chir"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2010.01365.x","article-title":"Cutaneous manifestations of breast carcinoma","volume":"23","author":"De Giorgi V","year":"2010","unstructured":"De Giorgi V, Grazzini M, Alfaioli B, Savarese I, Corciova SA, Guerriero G, Lotti T. Cutaneous manifestations of breast carcinoma. Dermatol Ther. 2010, 23:581-9. 10.1111\/j.1529-8019.2010.01365.x","journal-title":"Dermatol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.118918","article-title":"The presentation, pathology, and current management strategies of cutaneous metastasis","volume":"5","author":"Wong CY","year":"2013","unstructured":"Wong CY, Helm MA, Kalb RE, Helm TN, Zeitouni NC. The presentation, pathology, and current management strategies of cutaneous metastasis. N Am J Med Sci. 2013, 5:499-504. 10.4103\/1947-2714.118918","journal-title":"N Am J Med Sci"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e31819b0c26","article-title":"Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica","volume":"102","author":"Conner KB","year":"2009","unstructured":"Conner KB, Cohen PR. Cutaneous metastasis of breast carcinoma presenting as alopecia neoplastica. South Med J. 2009, 102:385-9. 10.1097\/SMJ.0b013e31819b0c26","journal-title":"South Med J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/129683","article-title":"Evaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET\/CT tumor imaging","volume":"2014","author":"Tasdemir B","year":"2014","unstructured":"Tasdemir B, Dostbil Z, Inal A, Unal K, Yildirim S, Simsek FS. Evaluation of clinical contributions provided by addition of the brain, calvarium, and scalp to the limited whole body imaging area in FDG-PET\/CT tumor imaging. Biomed Res Int. 2014, 2014:129683. 10.1155\/2014\/129683","journal-title":"Biomed Res Int"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2342-7-8","article-title":"Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET\/CT","volume":"7","author":"Nguyen NC","year":"2007","unstructured":"Nguyen NC, Chaar BT, Osman MM. Prevalence and patterns of soft tissue metastasis: detection with true whole-body F-18 FDG PET\/CT. BMC Med Imaging. 2007, 7:8. 10.1186\/1471-2342-7-8","journal-title":"BMC Med Imaging"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16330","article-title":"Malignant cutaneous tumours of the scalp: always remember to examine the head","volume":"34","author":"Dika E","year":"2020","unstructured":"Dika E, Patrizi A, Veronesi G, Manuelpillai N, Lambertini M. Malignant cutaneous tumours of the scalp: always remember to examine the head. J Eur Acad Dermatol Venereol. 2020, 34:2208-15. 10.1111\/jdv.16330","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1159\/000331417","article-title":"Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestations","volume":"81","author":"Kong JH","year":"2011","unstructured":"Kong JH, Park YH, Kim JA, et al.. Patterns of skin and soft tissue metastases from breast cancer according to subtypes: relationship between EGFR overexpression and skin manifestations. Oncology. 2011, 81:55-62. 10.1159\/000331417","journal-title":"Oncology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqx123.272","article-title":"273 metastatic breast carcinoma with CK7, GATA3, and ER expression? A diagnostic pitfall","volume":"149","author":"Wang H","year":"2018","unstructured":"Wang H, Nicolas M, Nazarullah A, et al.. 273 metastatic breast carcinoma with CK7, GATA3, and ER expression? A diagnostic pitfall. Am J Clin Pathol. 2018, 149:116. 10.1093\/ajcp\/aqx123.272","journal-title":"Am J Clin Pathol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2015.2286","article-title":"The evolving landscape of HER2 targeting in breast cancer","volume":"1","author":"Moasser MM","year":"2015","unstructured":"Moasser MM, Krop IE. The evolving landscape of HER2 targeting in breast cancer. JAMA Oncol. 2015, 1:1154-61. 10.1001\/jamaoncol.2015.2286","journal-title":"JAMA Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-025-01623-4","article-title":"Trichorhinophalangeal syndrome type 1 (TRPS1) in breast pathology: diagnostic utility and pitfalls","volume":"20","author":"Hashmi AA","year":"2025","unstructured":"Hashmi AA, Brogi E, Wen HY. Trichorhinophalangeal syndrome type 1 (TRPS1) in breast pathology: diagnostic utility and pitfalls. Diagn Pathol. 2025, 20:26. 10.1186\/s13000-025-01623-4","journal-title":"Diagn Pathol"},{"key":"ref34","article-title":"Diffuse cutaneous breast cancer metastases resembling subcutaneous nodules with no surface changes","volume":"101","author":"Mayer JE","year":"2018","unstructured":"Mayer JE, Maurer MA, Nguyen HT. Diffuse cutaneous breast cancer metastases resembling subcutaneous nodules with no surface changes. Cutis. 2018, 101:219-23.","journal-title":"Cutis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002201","article-title":"Mutational profile of metastatic breast cancers: a retrospective analysis","volume":"13","author":"Lefebvre C","year":"2016","unstructured":"Lefebvre C, Bachelot T, Filleron T, et al.. Mutational profile of metastatic breast cancers: a retrospective analysis. PLoS Med. 2016, 13:e1002201. 10.1371\/journal.pmed.1002201","journal-title":"PLoS Med"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2017.07.005","article-title":"Genomic evolution of breast cancer metastasis and relapse","volume":"32","author":"Yates LR","year":"2017","unstructured":"Yates LR, Knappskog S, Wedge D, et al.. Genomic evolution of breast cancer metastasis and relapse. Cancer Cell. 2017, 32:169-84. 10.1016\/j.ccell.2017.07.005","journal-title":"Cancer Cell"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2011.00014","article-title":"Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers","volume":"1","author":"Kinsella TJ","year":"2011","unstructured":"Kinsella TJ, Baron ED, Colussi VC, et al.. Preliminary clinical and pharmacologic investigation of photodynamic therapy with the silicon phthalocyanine photosensitizer pc 4 for primary or metastatic cutaneous cancers. Front Oncol. 2011, 1:14. 10.3389\/fonc.2011.00014","journal-title":"Front Oncol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13609","article-title":"Long\u2010term survival and complete response to anastrozole in breast cancer patient with cutaneous metastases only","volume":"39","author":"Sedloev T","year":"2019","unstructured":"Sedloev T, Vlahova A, Usheva S, Vasileva-Slaveva M, Spiridonova T, Spirdonov J. Long\u2010term survival and complete response to anastrozole in breast cancer patient with cutaneous metastases only. Anticancer Res. 2019, 39:4393-8. 10.21873\/anticanres.13609","journal-title":"Anticancer Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1002\/jso.26870","article-title":"Cutaneous metastasectomy: is there a role in breast cancer? A systematic review and overview of current treatment modalities","volume":"126","author":"Huang S","year":"2022","unstructured":"Huang S, Parekh V, Waisman J, et al.. Cutaneous metastasectomy: is there a role in breast cancer? A systematic review and overview of current treatment modalities. J Surg Oncol. 2022, 126:217-38. 10.1002\/jso.26870","journal-title":"J Surg Oncol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.67.1487","article-title":"Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology guideline","volume":"34","author":"Rugo HS","year":"2016","unstructured":"Rugo HS, Rumble RB, Macrae E, et al.. Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology guideline. J Clin Oncol. 2016, 34:3069-103. 10.1200\/JCO.2016.67.1487","journal-title":"J Clin Oncol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30804-6","article-title":"CDK4\/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis","volume":"21","author":"Gao JJ","year":"2020","unstructured":"Gao JJ, Cheng J, Bloomquist E, et al.. CDK4\/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Lancet Oncol. 2020, 21:250-60. 10.1016\/S1470-2045(19)30804-6","journal-title":"Lancet Oncol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2217\/fon.12.49","article-title":"The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer","volume":"8","author":"Beaver JA","year":"2012","unstructured":"Beaver JA, Park BH. The BOLERO-2 trial: the addition of everolimus to exemestane in the treatment of postmenopausal hormone receptor-positive advanced breast cancer. Future Oncol. 2012, 8:651-7. 10.2217\/fon.12.49","journal-title":"Future Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00137","article-title":"Overall survival with palbociclib plus letrozole in advanced breast cancer","volume":"42","author":"Slamon DJ","year":"2024","unstructured":"Slamon DJ, Di\u00e9ras V, Rugo HS, et al.. Overall survival with palbociclib plus letrozole in advanced breast cancer. J Clin Oncol. 2024, 42:994-1000. 10.1200\/JCO.23.00137","journal-title":"J Clin Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.04.013","article-title":"Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3","volume":"35","author":"Goetz MP","year":"2024","unstructured":"Goetz MP, Toi M, Huober J, et al.. Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3. Ann Oncol. 2024, 35:718-27. 10.1016\/j.annonc.2024.04.013","journal-title":"Ann Oncol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2114663","article-title":"Overall survival with ribociclib plus letrozole in advanced breast cancer","volume":"386","author":"Hortobagyi GN","year":"2022","unstructured":"Hortobagyi GN, Stemmer SM, Burris HA, et al.. Overall survival with ribociclib plus letrozole in advanced breast cancer. N Engl J Med. 2022, 386:942-50. 10.1056\/NEJMoa2114663","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1903765","article-title":"Overall survival with ribociclib plus endocrine therapy in breast cancer","volume":"381","author":"Im SA","year":"2019","unstructured":"Im SA, Lu YS, Bardia A, et al.. Overall survival with ribociclib plus endocrine therapy in breast cancer. N Engl J Med. 2019, 381:307-16. 10.1056\/NEJMoa1903765","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-023-01701-9","article-title":"Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+\/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant","volume":"25","author":"Neven P","year":"2023","unstructured":"Neven P, Fasching PA, Chia S, et al.. Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+\/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant. Breast Cancer Res. 2023, 25:103. 10.1186\/s13058-023-01701-9","journal-title":"Breast Cancer Res"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.00144","article-title":"Final results of RIGHT choice: ribociclib plus endocrine therapy versus combination chemotherapy in premenopausal women with clinically aggressive hormone receptor-positive\/human epidermal growth factor receptor 2-negative advanced breast cancer","volume":"42","author":"Lu YS","year":"2024","unstructured":"Lu YS, Mahidin EI, Azim H, et al.. Final results of RIGHT choice: ribociclib plus endocrine therapy versus combination chemotherapy in premenopausal women with clinically aggressive hormone receptor-positive\/human epidermal growth factor receptor 2-negative advanced breast cancer. J Clin Oncol. 2024, 42:2812-21. 10.1200\/JCO.24.00144","journal-title":"J Clin Oncol"},{"key":"ref49","article-title":"Cutaneous lesions as a presenting sign of metastases in male breast cancer: a rare clinical entity","volume":"68","author":"Poovaneswaran S","year":"2013","unstructured":"Poovaneswaran S, Lee ZEJ, Lim WY, et al.. Cutaneous lesions as a presenting sign of metastases in male breast cancer: a rare clinical entity. Med J Malaysia. 2013, 68:168-70.","journal-title":"Med J Malaysia"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S456532","article-title":"Scalp metastasis after breast cancer surgery: a case report","volume":"17","author":"Wu J","year":"2024","unstructured":"Wu J, Zhang W, Zhang H, et al.. Scalp metastasis after breast cancer surgery: a case report. Onco Targets Ther. 2024, 17:411-9. 10.2147\/OTT.S456532","journal-title":"Onco Targets Ther"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S174577","article-title":"Scalp metastases as first presentation of pulmonary adenocarcinomas: a case report","volume":"11","author":"Yu Q","year":"2018","unstructured":"Yu Q, Subedi S, Tong Y, et al.. Scalp metastases as first presentation of pulmonary adenocarcinomas: a case report. Onco Targets Ther. 2018, 11:6147-51. 10.2147\/OTT.S174577","journal-title":"Onco Targets Ther"},{"key":"ref52","article-title":"Survival after cutaneous metastasis: a study of 200 cases (Article in French)","volume":"128","author":"Schoenlaub P","year":"2001","unstructured":"Schoenlaub P, Sarraux A, Grosshans E, et al.. Survival after cutaneous metastasis: a study of 200 cases (Article in French). Ann Dermatol Venereol. 2001, 128:1310-5.","journal-title":"Ann Dermatol Venereol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/480754-extensive-cutaneous-and-scalp-metastases-from-hormone-receptor-positive-breast-cancer-successfully-treated-with-cdk46-inhibitor-therapy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:04:12Z","timestamp":1777903452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/480754-extensive-cutaneous-and-scalp-metastases-from-hormone-receptor-positive-breast-cancer-successfully-treated-with-cdk46-inhibitor-therapy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":52,"URL":"https:\/\/doi.org\/10.7759\/cureus.108234","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,4]]}}}